Related Experiment Video
Updated: Oct 7, 2025
10:28
An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
Published on: June 7, 2015
17.5K
Microsphere-Embedded Hydrogel Sustained-Release System to Inhibit Postoperative Epidural Fibrosis
Shuguang Wang1, Kun Shi2, Jiawei Lu1
1Department of Orthopedics, East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
ACS Applied Bio Materials
|January 10, 2022
Summary
This study introduces a novel hydrogel combining GelMA and resveratrol-loaded PLGA microspheres to combat epidural fibrosis after spine surgery. This innovative approach effectively inhibits fibroblast activity and reduces fibrosis, offering a promising treatment for failed back surgery syndrome.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Spine Surgery Research
Background:
- Postoperative epidural fibrosis is a common complication following spine surgery, leading to failed back surgery syndrome (FBSS).
- Current clinical interventions for epidural fibrosis are limited and often ineffective.
- Developing novel strategies to prevent or treat epidural fibrosis is crucial for improving surgical outcomes.
Purpose of the Study:
- To develop and evaluate a novel hydrogel-based drug delivery system for inhibiting epidural fibrosis.
- To combine gelatin methacryloyl (GelMA) hydrogel with poly(lactic-co-glycolic acid) (PLGA) microsphere-encapsulated resveratrol (RSV) for synergistic antifibrotic effects.
- To assess the efficacy and mechanism of the developed hydrogel in a preclinical model.
Main Methods:
- Fabrication of RSV-loaded PLGA microspheres and their incorporation into a GelMA hydrogel matrix (RSV@PLGA-GelMA).
- Characterization of hydrogel mechanical properties, drug release kinetics, and in vitro biosafety (cytotoxicity).
- Evaluation of the hydrogel's effect on fibroblast proliferation and migration in vitro.
- Assessment of the hydrogel's efficacy in reducing epidural fibrosis in a rat laminectomy model, including analysis of the TGF-β/Smad signaling pathway.
Main Results:
- The RSV@PLGA-GelMA hydrogels demonstrated optimal mechanical properties and sustained resveratrol release over several weeks.
- The hybrid hydrogels exhibited good biosafety with no significant cytotoxicity.
- RSV@PLGA-GelMA effectively inhibited fibroblast proliferation and migration in vitro.
- In vivo studies showed that RSV@PLGA-GelMA hydrogels significantly reduced epidural fibrosis by suppressing fibroblast activity and extracellular matrix deposition via the TGF-β/Smad pathway.
Conclusions:
- The combination of GelMA hydrogel and RSV-loaded PLGA microspheres provides a promising strategy for preventing postoperative epidural fibrosis.
- This novel biomaterial effectively targets key fibrotic mechanisms, offering a potential therapeutic solution for FBSS.
- The developed hydrogel system holds significant potential for clinical application in spine surgery to mitigate complications.
